News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aurigene Discovery Technologies Limited And Merck Serono Enter A Discovery Collaboration To Identify Therapeutics For Autoimmune Disorders


2/2/2007 3:10:53 PM

Bangalore, India – February 2nd, 2007 – Aurigene Discovery Technologies Ltd (Aurigene), a Bangalore-based integrated drug discovery services company, announced today that it has entered into a discovery collaboration with Merck Serono International S.A (Merck Serono), a global biotechnology leader. The two companies have entered into an agreement to identify small molecule drugs for the treatment of autoimmune diseases such as multiple sclerosis, and rheumatoid arthritis.


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES